methylprednisolone has been researched along with Kawasaki Disease in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (5.75) | 18.2507 |
2000's | 40 (45.98) | 29.6817 |
2010's | 32 (36.78) | 24.3611 |
2020's | 10 (11.49) | 2.80 |
Authors | Studies |
---|---|
Akashi, M; Okada, T; Oku, T; Shinabe, Y; Yokota, I | 1 |
Mărginean, CO; Mărginean, MO; Meliţ, LE | 1 |
Beukelman, T; Crayne, CB; Mitchell, C | 1 |
Bogatu, B; Kerl, K; Pachlopnik-Schmid, J; Pleimes, M; Theiler, M; Weibel, L; Weins, AB | 1 |
Chang, LS; Kuo, HC | 1 |
Furui, S; Goto, M; Minami, T; Seki, M; Yamagata, T | 1 |
Li, L; Liu, L; Shi, X; Song, Y; Wang, Y; Wei, W | 1 |
Cimaz, R; Corsello, G; Dones, P; Failla, MC; Maggio, MC | 1 |
Gupta, A; Jindal, AK; Johnson, N; Pilania, RK; Prithvi, A; Rawat, A; Singh, S; Suri, D; Vignesh, P | 1 |
Chen, F; Huang, P; Li, W; Liu, P; Wang, Y; Wang, Z; Xie, X; Zhang, L; Zhang, X | 1 |
Chowdhary, S; Garg, A; Raj, D; Renganathan, A | 1 |
Li, A; Li, X; Liu, Y; Shi, L; Yang, S; Zhang, M; Zheng, Y | 1 |
Fushimi, K; Matsui, H; Michihata, N; Morisaki, N; Okubo, Y; Sundel, RP; Yasunaga, H | 1 |
Ebato, T; Fujimoto, M; Ishii, M; Kitagawa, A; Ogata, S; Ogihara, Y; Takanashi, M | 1 |
Guile, L; Kelly, A; Parke, S; Tulloh, R | 1 |
Censoplano, N; Flori, H; Gorga, S; Rabah-Hammad, R; Stillwell, T; Waldeck, K | 1 |
Deng, H; Du, M; Fu, J; Liu, R; Wan, H; Wang, X; Zhang, Y | 1 |
Ng, SH; Roshan, S | 1 |
Chan, H; Chi, H; Li, Q; Wang, M; Yang, H; You, H; Zhang, G | 1 |
Butragueño-Laiseca, L; García-San Prudencio, M; López-González, J; Rincón-López, E; Vigil-Vázquez, S | 1 |
Barone, P; Di Stefano, V; Gravina, G; La Rosa, M; Leonardi, S; Parisi, GF; Sciacca, P | 1 |
Farley, LF; Hodo, LN | 1 |
Kawasaki, T; Naoe, S | 1 |
Kundu, R; Mukherjee, D; Niyogi, P; Pal, P | 1 |
Bœuf, B; Dauphin, C; Lang, M; Lusson, JR; Merlin, E; Tissandier, C | 1 |
Gargalskaite, U; Gedminaite, A; Panaviene, V; Petrulioniene, Z; Serpytis, P | 1 |
Miura, M | 1 |
Matsui, M; Matsushita, T; Okuma, Y; Sato, N; Shichino, H; Uryu, H; Yamanaka, J | 1 |
Stowe, RC | 1 |
Abe, J; Hamahira, K; Horinouchi, T; Iijima, K; Inaguma, Y; Kugo, M; Nakajima, H; Nozu, K | 1 |
Connolly, GM; Seager, MJ; Tulloh, RM; Wardle, AJ | 1 |
Koh, YK; Lee, JH; Park, YB | 1 |
Kawano, Y; Kono, Y; Nishikawa, T; Nomura, Y | 1 |
Ando, H; Bando, Y; Furukawa, S; Ishii, M; Kaida, M; Kaneko, T; Kimura, S; Minoura, K; Nakahata, Y; Ogata, S; Ogihara, Y; Yokota, Y | 1 |
Prabhu, SS; Shah, I | 1 |
Calcagno, G; Conti, G; Falcini, F; Fede, C; La Torre, F; Vitale, A | 1 |
Akiyama, K; Ishii, M; Kobayashi, H; Kokubo, K; Minoura, K; Nakahata, Y; Nomoto, K; Ogata, S; Ogihara, Y; Sato, K | 1 |
Choi, JY; Girish, M; Kim, DS; Lee, JS; Shin, JI | 1 |
Demirpençe, S; Güven, B; Meşe, T; Oner, T; Tavli, V; Yilmazer, MM | 1 |
Shirley, DA; Stephens, I | 1 |
Akiyama, K; Honda, T; Ishii, M; Kon, S; Ogata, S; Ogihara, Y | 1 |
Floriańczyk, T; Gołąbek-Dylewska, M; Werner, B | 1 |
Alexopoulos, A; Kakourou, T; Lagona, E; Lycopoulou, L; Tavena, A; Vekiou, A | 1 |
Bajolle, F; Laux, D | 1 |
Clausen, H; Giardini, A; Howarth, C | 1 |
Dogra, S; Gehlot, A; Kumar, RM; Rawat, A; Singh, S; Suri, D | 1 |
Kaneko, K; Kino, M; Ogino, H; Okazaki, H; Taniuchi, S; Teraguchi, M; Yoshimura, K | 1 |
Sundel, RP | 1 |
Harada, W; Hirokawa, T; Suzuki, H; Toyabe, S; Uchiyama, M | 1 |
Shulman, ST | 1 |
Baker, AL; Fulton, DR; Newburger, JW; Sundel, RP | 1 |
Achterhuis, A; Becker, AE; Biezeveld, M; Hack, CE; Kuijpers, TW; Kuipers, I; Lam, J; van der Wal, AC | 1 |
Barbarini, G; Barbaro, G; Di Lorenzo, G | 1 |
Al-Mayouf, SM | 1 |
Chiu, CH; Hung, JJ | 1 |
Chowdhury, D; Eberhard, BA; Gottlieb, BS; Weiss, JE | 1 |
Freeman, AF; Shulman, ST | 1 |
Lehman, TJ | 1 |
Cao, XJ; Wang, YQ | 1 |
Bong, CN; Chen, HH; Liu, PM; Wang, CL; Wu, YT; Yang, KD | 1 |
Miura, M; Ohki, H; Satoh, M; Sugaya, A; Ueda, H; Yamagishi, H; Yoshiba, S | 1 |
Ebbeson, R; Feldman, BM; Huber, AM; Lang, BA; Laxer, RM; Malleson, PN; McCrindle, BW; Oen, KG; Ramsey, SE; Ratnapalan, S; Riley, M; Silverman, ED; Yeung, RS | 1 |
Gong, FQ; Huang, XM; Kang, ML; Qian, BQ; Zhang, YY | 1 |
Calabri, GB; de Martino, M; Falcini, F; Poggi, GM; Ricci, L; Simonini, G | 1 |
Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME | 1 |
Phornphutkul, C; Pongprot, Y; Silvilairat, S; Sittiwangkul, R | 1 |
Burns, JC | 1 |
Atz, AM; Baker, AL; Colan, SD; Gersony, W; Klein, GL; Li, JS; McCrindle, BW; Minich, LL; Mitchell, PD; Newburger, JW; Sleeper, LA; Sundel, RP; Takahashi, M; Vetter, VL | 1 |
Hrycek, A; Olszanecka-Glinianowicz, M; Wanat-Wiśniewska, M | 1 |
O'connor, MJ; Saulsbury, FT | 1 |
Rosé, CD; Taddio, A | 1 |
Akimoto, K; Furukawa, T; Kishiro, M; Nagata, S; Shimizu, T; Yamashiro, Y | 1 |
Kohno, K; Miura, M; Ohki, H; Satoh, M; Sugaya, A; Yoshiba, S | 1 |
Kohno, K; Matsuoka, M; Miura, M; Ohki, H; Yoshiba, S | 1 |
Hara, J; Kurotobi, S; Maki, I; Matsuoka, T; Matsuzaki, K; Miki, K; Nishigaki, T; Okada, K; Sano, T; Yamamoto, T | 1 |
Baker, A; Newburger, JW; Sundel, RP; Wright, DA | 1 |
Rowley, AH; Shulman, ST | 1 |
Gedalia, A; Homsi, O; Shetty, AK; Ward, K | 1 |
Dahlem, PG; Kuijpers, TW; Lam, J; von Rosenstiel, IA | 1 |
French, JW; Kahn, SJ; Sherry, DD; Wallace, CA | 1 |
Han, RK; McCrindle, BW; Newman, A; Silverman, ED | 1 |
Ibe, M; Miyamae, T; Mori, M; Mori, T; Nakasima, S; Tomono, N; Yasui, K; Yokota, S | 1 |
Huang, YC; Kao, HT; Lin, TY | 1 |
Akagi, T; Hashino, K; Iemura, M; Ishii, M; Kato, H | 1 |
Chatila, T; Kim, J; Raman, V; Sharkey, A | 1 |
Caputo, AE; Posner, MP; Roberts, WN; Yee, YS | 1 |
12 review(s) available for methylprednisolone and Kawasaki Disease
Article | Year |
---|---|
Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.
Topics: Anti-Inflammatory Agents; Humans; Immunoglobulins, Intravenous; Infliximab; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Retreatment; Treatment Failure | 2019 |
The role of corticosteroids in the treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents; Coronary Artery Disease; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Precision Medicine; Prognosis; Pulse Therapy, Drug; Time Factors | 2020 |
Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Topics: Anti-Inflammatory Agents; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infliximab; Infusions, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Publication Bias | 2019 |
History of Kawasaki disease.
Topics: Antibodies, Monoclonal; Child, Preschool; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Infliximab; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Vasculitis | 2014 |
Kawasaki disease refractory to standard treatments that responds to a combination of pulsed methylprednisolone and plasma exchange: Cytokine profiling and literature review.
Topics: Child, Preschool; Female; Humans; Interleukin-6; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Plasma Exchange; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II | 2015 |
Corticosteroids for the treatment of Kawasaki disease in children.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Coronary Artery Disease; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prednisolone; Randomized Controlled Trials as Topic | 2017 |
[Kawasaki disease: what you need to know].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Child, Preschool; Combined Modality Therapy; Controlled Clinical Trials as Topic; Coronary Artery Disease; Diagnosis, Differential; Humans; Immunoglobulins; Infant; Infliximab; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prognosis; Pulse Therapy, Drug; Tumor Necrosis Factor-alpha | 2012 |
Update on the treatment of Kawasaki disease in childhood.
Topics: Abciximab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Aspirin; Child; Humans; Immunoglobulin Fab Fragments; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Plasmapheresis; Salvage Therapy; Tumor Necrosis Factor-alpha | 2002 |
Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect.
Topics: Aneurysm; C-Reactive Protein; Coronary Disease; Cyclosporine; Cytokines; Drug Resistance; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Salicylates; Serine Endopeptidases | 2003 |
Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Topics: Child, Preschool; Drug Resistance; Glucocorticoids; Heart Aneurysm; Humans; Immunoglobulins; Infant; Injections, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug; Treatment Outcome | 2004 |
Refractory Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Cyclosporine; Drug Therapy, Combination; Fever; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2004 |
[Updates on diagnosis and management of Kawasaki disease unresponsive to intravenous gamma globulin].
Topics: gamma-Globulins; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2005 |
8 trial(s) available for methylprednisolone and Kawasaki Disease
Article | Year |
---|---|
The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
Topics: Acute Disease; Anti-Inflammatory Agents; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Coronary Aneurysm; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infliximab; Injections, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Plasma Exchange; Treatment Outcome | 2017 |
Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.
Topics: Antibodies, Bacterial; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prospective Studies; Treatment Outcome; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2015 |
Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Topics: Child, Preschool; Drug Resistance; Drug Therapy, Combination; Echocardiography; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infusions, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2012 |
Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
Topics: Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Infant; Length of Stay; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prospective Studies | 2003 |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infusions, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2007 |
Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
Topics: Acute Disease; Adult; Chemokine CCL2; Cytokines; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Interleukin-6; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug; Receptors, Interleukin-2; Steroids; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2008 |
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
Topics: Child, Preschool; Drug Administration Schedule; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 1996 |
Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Coronary Disease; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug; Treatment Failure | 2001 |
67 other study(ies) available for methylprednisolone and Kawasaki Disease
Article | Year |
---|---|
Pulsed methylprednisolone for multisystem inflammatory syndrome in a Japanese boy.
Topics: Humans; Japan; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; SARS-CoV-2; Systemic Inflammatory Response Syndrome | 2022 |
The peculiarities of Kawasaki disease at the extremes of age: Two case reports.
Topics: Child; Coronary Aneurysm; Coronary Vessels; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2019 |
Febrile ulceronecrotic Mucha-Habermann disease mimicking Kawasaki disease.
Topics: Biopsy; Dermatologic Agents; Diagnosis, Differential; Glucocorticoids; Herpes Simplex; Humans; Infant; Male; Methotrexate; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pityriasis Lichenoides; Skin; Treatment Outcome | 2020 |
A case of Kawasaki disease complicated by acute disseminated encephalitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Encephalomyelitis, Acute Disseminated; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukocyte Count; Magnetic Resonance Imaging; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2020 |
Kawasaki disease shock syndrome complicated with bilateral lung consolidation in a child: A case report.
Topics: Child, Preschool; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Norepinephrine; Pulmonary Atelectasis; Shock; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2020 |
Typical Kawasaki disease with atypical pneumonia: a paediatric case report.
Topics: Child, Preschool; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pneumonia; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Topics: Child; Child, Preschool; Coronary Aneurysm; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; India; Infant; Infliximab; Macrophage Activation Syndrome; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prednisolone; Pulse Therapy, Drug; Tertiary Healthcare; Thrombocytopenia | 2021 |
Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Clinical Decision-Making; Disease Management; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome; Young Adult | 2020 |
SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.
Topics: Anti-Inflammatory Agents; Antibodies, Viral; Child; COVID-19; Echocardiography; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence; SARS-CoV-2; Treatment Outcome | 2021 |
Refractory Kawasaki disease: modified methylprednisolone regimen decreases coronary artery dilatation.
Topics: Coronary Aneurysm; Coronary Artery Disease; Dilatation; Humans; Immunoglobulins, Intravenous; Infant; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Retrospective Studies | 2022 |
Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease.
Topics: Child, Preschool; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prednisolone; Random Allocation | 2018 |
Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Coronary Vessels; Diagnosis, Differential; Echocardiography; Female; Humans; Immunoglobulins; Infant; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2018 |
Neonatal Adenovirus Infection Complicated by Hemophagocytic Lymphohistiocytosis Syndrome.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Dexamethasone; Female; Glucocorticoids; Humans; Immunocompromised Host; Infant, Newborn; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2018 |
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Mannitol; Meningitis, Aseptic; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Serum Albumin, Human | 2018 |
A case report of refractory kawasaki disease.
Topics: Anti-Inflammatory Agents; Humans; Immunoglobulins, Intravenous; Infant; Malaysia; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2018 |
A Case of Kawasaki Disease Presenting as Severe Myositis.
Topics: Child; Fever; Humans; Infliximab; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Myositis | 2019 |
Severe Kawasaki disease in a 3-month-old patient: a case report.
Topics: Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2013 |
An 8-year-old male with 4 days of fever, abdominal pain, and jaundice.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cardiomyopathy, Dilated; Ceftriaxone; Child; Clindamycin; Conjunctivitis; Diagnosis, Differential; Fever; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infliximab; Jaundice; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Nafcillin; Shock, Septic; Sodium Chloride; Treatment Outcome | 2014 |
Macrophage activation syndrome in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Macrophage Activation Syndrome; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2014 |
Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).
Topics: Algorithms; Antibodies, Monoclonal; Anticoagulants; Child; Glucocorticoids; Glycoproteins; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infliximab; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Prednisolone | 2014 |
Kawasaki shock syndrome complicating a recurrence of Kawasaki disease.
Topics: Aspirin; Child; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Heart Failure; Humans; Hypotension; Immunization, Passive; Inflammation Mediators; Intensive Care Units, Pediatric; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence; Shock | 2014 |
Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.
Topics: Adolescent; Anti-Inflammatory Agents; Aspirin; Coronary Aneurysm; Drug-Eluting Stents; Echocardiography; Electrocardiography; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Physical Examination | 2015 |
[Steroid pulse therapy].
Topics: Anti-Inflammatory Agents; Drug Combinations; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2014 |
Facial nerve palsy, Kawasaki disease, and coronary artery aneurysm.
Topics: Anti-Inflammatory Agents; Coronary Aneurysm; Echocardiography; Facial Nerve Diseases; Facial Paralysis; Female; Humans; Immunoglobulins, Intravenous; Infant; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2015 |
Extremely refractory Kawasaki disease with disseminated intravascular coagulation.
Topics: Coronary Aneurysm; Death, Sudden, Cardiac; Disseminated Intravascular Coagulation; Echocardiography; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Infant; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2017 |
Selective IgA deficiency complicated by Kawasaki syndrome.
Topics: Child, Preschool; Glucocorticoids; Humans; IgA Deficiency; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2008 |
The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Topics: Child; Child, Preschool; Coronary Aneurysm; Drug Resistance; Female; Fever; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug; Steroids; Vasculitis | 2009 |
Response of refractory Kawasaki disease to intravenous methylprednisolone.
Topics: Child, Preschool; Coronary Aneurysm; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Injections, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Failure | 2009 |
Refractory pneumonia and high fever.
Topics: Anti-Inflammatory Agents; Child, Preschool; Conjunctivitis; Coronary Disease; Female; Fever of Unknown Origin; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pleural Effusion; Pneumonia; Thrombocytosis | 2009 |
Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone.
Topics: Coronary Vessels; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Oligonucleotide Array Sequence Analysis; Oncostatin M; Receptors, Interleukin-1; Receptors, Interleukin-18; RNA, Messenger; S100 Proteins; S100A12 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Treatment Outcome | 2009 |
Refractory Kawasaki disease: infliximab or methotrexate therapy?
Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Tumor Necrosis Factor-alpha | 2009 |
[Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
Topics: Age of Onset; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Echocardiography; Female; gamma-Globulins; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Failure; Treatment Outcome | 2010 |
Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
Topics: Antibodies, Monoclonal; Child, Preschool; Coronary Aneurysm; Humans; Immunologic Factors; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2010 |
[Therapeutic difficulties in a 3 year-old boy with Kawasaki disease].
Topics: Child, Preschool; Coronary Aneurysm; Delayed Diagnosis; Echocardiography; Humans; Immunoglobulins; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2011 |
Kawasaki disease in Greek children: a retrospective study.
Topics: Antibodies, Monoclonal; Child; Child, Preschool; Female; Greece; Humans; Infant; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; Seasons | 2013 |
Kawasaki disease: always straight to the heart?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Child; Hearing Loss, Sensorineural; Heart Diseases; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2012 |
Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma.
Topics: Administration, Oral; Antibodies, Monoclonal; Arthritis, Juvenile; Diagnosis, Differential; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Immunization, Passive; Infant; Infliximab; Infusions, Intravenous; Injections, Subcutaneous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2013 |
Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
Topics: Albumins; C-Reactive Protein; Chi-Square Distribution; Child; Child, Preschool; Female; Humans; Immunoglobulins, Intravenous; Infant; Leukocyte Count; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prospective Studies; Pulse Therapy, Drug; Statistics, Nonparametric; Treatment Outcome | 2013 |
Large vessel arteritis associated with human herpesvirus 6 infections.
Topics: Angiography; Aorta; Arteritis; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; DNA, Viral; Fluorescent Antibody Technique, Indirect; Herpesvirus 6, Human; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Polymerase Chain Reaction; Roseolovirus Infections; Virus Replication | 2002 |
Is there a role for corticosteroids in Kawasaki disease?
Topics: Child; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2003 |
Kawasaki-like syndrome in an HIV-infected adult.
Topics: Adult; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; Aspirin; Drug Therapy, Combination; HIV Infections; Homosexuality, Male; Humans; Immunoglobulin A; Injections, Intramuscular; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Plasma Cells | 2003 |
The use of corticosteroid therapy in refractory Kawasaki patients.
Topics: Child; Child, Preschool; Drug Resistance; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Injections, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; Treatment Outcome | 2004 |
Infliximab as a novel therapy for refractory Kawasaki disease.
Topics: Antibodies, Monoclonal; Child, Preschool; Coronary Aneurysm; Echocardiography; Humans; Immunoglobulins, Intravenous; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Failure; Tumor Necrosis Factor-alpha | 2004 |
Clinical trials in Kawasaki disease.
Topics: Child; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Randomized Controlled Trials as Topic | 2004 |
Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Lymphatic Diseases; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Neck; Taiwan | 2005 |
Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
Topics: Anticoagulants; Drug Therapy, Combination; Glucocorticoids; Heparin; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2005 |
Corticosteroid treatment of refractory Kawasaki disease.
Topics: Child; Child, Preschool; Female; Fever; Glucocorticoids; Humans; Infant; Injections, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pediatrics; Recurrence; Retrospective Studies; Treatment Failure; Treatment Outcome | 2006 |
[Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Aspirin; Biomarkers; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flow Cytometry; Glucocorticoids; HLA-DR Antigens; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Prognosis; T-Lymphocytes; Treatment Outcome | 2006 |
Severe cutaneous manifestations in a child with refractory Kawasaki disease.
Topics: Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Skin Diseases, Vesiculobullous | 2006 |
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Antithrombin III; Aspirin; Dipyridamole; Foot; Gangrene; Glucocorticoids; Heparin; Humans; Immunoglobulin Fab Fragments; Immunoglobulins, Intravenous; Infant; Ischemia; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents | 2006 |
Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Topics: Adolescent; Adult; Blood Sedimentation; Case-Control Studies; Drug Resistance; Female; gamma-Globulins; Glucocorticoids; Humans; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Failure; Treatment Outcome | 2006 |
Revisiting steroids in the primary treatment of acute Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2006 |
[Case report of patient with systemic lupus erythematosus proceed with lymphadenopathy].
Topics: Diagnosis, Differential; Female; Histiocytic Necrotizing Lymphadenitis; Humans; Inflammation; Lupus Erythematosus, Systemic; Lymphatic Diseases; Methylprednisolone; Middle Aged; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2006 |
Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Aspirin; Coronary Aneurysm; Gangrene; Heparin; Humans; Immunoglobulins, Intravenous; Infant; Infliximab; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Ultrasonography | 2007 |
Treatment of Kawasaki disease.
Topics: Coronary Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infusions, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2007 |
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Clinical Protocols; Coronary Aneurysm; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Pulse Therapy, Drug; Retrospective Studies; Treatment Failure; Treatment Outcome | 2008 |
[Methylprednisolone pulse therapy in Kawasaki disease].
Topics: Child, Preschool; Drug Resistance; Humans; Immunoglobulins, Intravenous; Infant; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug | 2008 |
Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease.
Topics: Aspartate Aminotransferases; Bilirubin; C-Reactive Protein; Child, Preschool; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; gamma-Globulins; Heparin; Humans; Infant; Infusions, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pulse Therapy, Drug; Risk Factors; Treatment Outcome | 2009 |
Treatment of Kawasaki disease with corticosteroid.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 1996 |
Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: success with pulse steroid therapy.
Topics: Airway Obstruction; Anti-Inflammatory Agents; Child, Preschool; Female; Humans; Injections, Intravenous; Lymphatic Diseases; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Neck; Tomography, X-Ray Computed | 1998 |
Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac Tamponade; Child; Diagnosis, Differential; Disease Progression; Drug Administration Schedule; Echocardiography; Electrocardiography; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pericardial Effusion; Pleural Effusion; Time Factors | 1999 |
Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Coronary Thrombosis; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infusions, Intravenous; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; Risk Factors; Treatment Failure | 2000 |
Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Combined Modality Therapy; Coronary Aneurysm; Female; Fever; Follow-Up Studies; Humans; Immunization, Passive; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Outcome and Process Assessment, Health Care; Recurrence; Retreatment | 2000 |
[Two infants with classical polyarteritis nodosa but not Kawasaki disease].
Topics: Cyclophosphamide; Diagnosis, Differential; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Polyarteritis Nodosa; Pulse Therapy, Drug | 2000 |
Kawasaki disease presenting as cervical lymphadenitis or deep neck infection.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Bacterial Infections; Child; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; gamma-Globulins; Humans; Immunoglobulins, Intravenous; Infant; Lymphadenitis; Male; Methylprednisolone; Middle Aged; Mucocutaneous Lymph Node Syndrome; Neck | 2001 |
Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2001 |
Hepatic artery aneurysm in corticosteroid-treated, adult Kawasaki's disease.
Topics: Adult; Aneurysm; Arteriosclerosis; Hepatic Artery; Humans; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 1991 |